🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
VCE
$VCEL
🔒 US EquitiesVericel Corporation
AVG HISTORICAL GAP
+0.29%
MAX GAP RECORD
+11.88%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $VCEL
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$VCEL
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Jul 30, 2026 Earnings Release 2026-07-30 (UNDETERMINED) |
+0.00%
|
| May 07, 2026 Earnings Release 2026-05-07 (BEFORE OPEN) |
+10.11%
|
| Feb 26, 2026 Earnings Release 2026-02-26 (AFTER CLOSE) |
-2.71%
|
| Nov 06, 2025 Earnings Release 2025-11-06 (BEFORE OPEN) |
+11.88%
|
| Jul 31, 2025 Earnings Release 2025-07-31 (BEFORE OPEN) |
-9.05%
|
| May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE) |
-0.54%
|
| Feb 27, 2025 Earnings Release 2025-02-27 (BEFORE OPEN) |
+3.75%
|
| Nov 07, 2024 Earnings Release 2024-11-07 (BEFORE OPEN) |
+2.48%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
5.4%
Bullish Gaps (6)
Bearish Gaps (5)
Neutral / Flat (1)
📖 Intelligence Summary
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗